Understanding genotype-phenotype relationship is a central problem in modern biology. Here we report that several destabilizing mutations in E. coli Dihydrofolate Reductase (DHFR) enzyme result in pronounced yet reversible filamentation of bacterial cells. We find that drop in DHFR activity in the mutants results in massive metabolic shifts leading to significant excess of dUMP and dCTP in the pyrimidine biosynthesis pathway. Both deoxyribonucleotides inhibit downstream essential enzyme Thymidylate Kinase (Tmk) which phosphorylates dTMP, eventually leading to almost complete loss of the DNA building block dTTP. Severe imbalance in deoxyribonucleotide levels ultimately leads to DNA damage, SOS response and filamentation. Supplementation of dTMP in the medium competitively alleviates Tmk inhibition and rescues filamentation, thereby illustrating a classic case of enzyme inhibition by structural mimic of its cognate ligand. Overall, this study highlights the complex interconnected nature of the metabolic network, and the fundamental role of folate metabolism in shaping the cell.
Introduction
Phenotype or fitness of microorganisms is often viewed in terms of different growth components, such as growth rate, duration of the lag phase, biomass yield at saturation, etc.
However, the effect of mutations on cell morphology has received much less attention (Bollenbach et al., 2009; Monds et al., 2014) . Microorganisms, most importantly bacteria, come in many different shapes and sizes, for example, rod-like, curved, helical, filamentous, round, flat sided, bean shaped, to name a few (Young, 2006) . Despite this natural diversity, within a given species the shape remains surprisingly uniform, pointing towards the role of selection in 'shaping the bacteria' (Persat et al., 2014; Young, 2006) . Moreover, several bacteria actively change their shape in response to changing environmental conditions (nutritional starvation (James et al., 1995; Pine and Boone, 1967; Ruoff, 1991) , protection against predation by protists (Pernthaler, 2005) , escape from immune cells (Champion and Mitragotri, 2006) , or while going through different stages of the life-cycle. The best example of how bacterial shape contributes to virulence is exemplified by an uropathogenic E. coli that changes its shape from rod-like structures to 50μm-long filaments to resist phagocytosis and promote infection (Horvath et al., 2011; Justice et al., 2006) .
Considering that cellular morphology has been important in microbial evolution, an important question is: How do mutations affect cell shape? The most common mutations that change cell shape and size are those associated with Fts family of proteins, which are directly involved in the formation of Z-ring during division (Addinall et al., 2005; Bi and Lutkenhaus, 1990; Pichoff et al., 2012) . In E. coli and B. subtilis, studies have shown that mutations in peptidoglycan synthesis proteins (pbpA, rodA) Wei et al., 2003) , and those in the bacterial mreBCD family of proteins (Kruse et al., 2003) disrupt cell shape by interfering with cell wall and cytoskeleton formation, respectively. Defects in chromosome partitioning have been shown to produce anucleate cells and cells of aberrant sizes .
These studies focused on proteins directly involved in maintaining cell shape and divisions.
However, mutations (or other loss of function such as inhibition by an antibiotic) in metabolic enzymes are also known to cause filamentation (Fonville et al., 2010; Sperber and Herman, 2017) . A well-studied example is thymineless death (TLD) where cells acquire filamentous phenotype upon severe deprivation of essential metabolite thymine (Ahmad et al., 1998) .
However, despite considerable effort, a mechanistic understanding of why bacterial cell shape can be sensitive to metabolic changes has been lacking.
In this work, we uncover that destabilizing mutations in the essential E. coli enzyme dihydrofolate reductase (DHFR) result in pronounced (>10 times of the normal cells) filamentation. DHFR catalyzes conversion of dihydrofolate to tetrahydrofolate, which is an essential one-carbon donor in purine, pyrimidine and amino acid biosynthesis pathways.
Metabolomics analyses reveals that drop in DHFR activity in mutants leads to accumulation of metabolic precursors upstream in the pyrimidine biosynthesis pathway that, in turn, competitively inhibit another essential enzyme thymidylate kinase (Tmk), in a domino-like effect. Tmk phosphorylates dTMP (thymidine monophosphate) to dTDP, eventually to produce dTTP. As a result, severe imbalance in the concentrations of deoxyribonucleotide levels results in DNA damage, upregulation of SOS response, and filamentation. While triggered by dTTP loss, filamentation in mutant DHFR strains appears to be completely reversible under permissive conditions and differs from the characteristic thymineless death (Ahmad et al., 1998; Sangurdekar et al., 2010; Sangurdekar et al., 2011; Zaritsky et al., 2006) . In fact, mutants in our study were found to phenotypically and metabolically resemble sub-MIC (sub-lethal) concentrations of trimethoprim (TMP) treatment that partially inhibits DHFR. Hence this phenomenon has important implications in tolerance, resistance and persistence of bacteria under sub-lethal doses of antibiotic treatment. Overall, this study highlights the pleiotropic nature of mutations and the complex connectivity of the metabolic network, where mutations can have "unintended" effects that extend far beyond its immediate metabolic vicinity.
Results

Several chromosomal mutations in folA gene give rise to slow growth and filamentation of E. coli
Earlier we reported that a group of highly destabilizing chromosomal DHFR mutations (W133V, V75H+I155A, I91L+W133V, and V75H+I91L+I155A) cause very slow growth of bacteria at 37 o C and 42 o C ( (Bershtein et al., 2013; Bershtein et al., 2012) and Figure 1A ). To understand the effects of these mutations on bacterial morphology, we grew those under two different growth conditions:
M9 minimal media without and with supplementation with casamino acids (mixtures of all amino acids, except tryptophan, see Methods). In minimal media, median cell lengths of some mutants (W133V and V75H+W133V at 42°C) were smaller compared to WT, while I91L+W133V (at 40°C) was marginally longer than WT ( Figure 1B ). Since the mutant cells grew much slower than WT, reduction in size was expected in accordance with the 'growth law' that shows a positive correlation between cell size and growth rate (Dai et al., 2018; Vadia and Levin, 2015) . However, when M9 minimal medium was supplemented with amino acids, we found that cells carrying these mutations were pronouncedly filamentous. Figure 1C , D shows live cell DIC images of wild-type (WT) and I91L+W133V mutant DHFR strains at 30°C, 37°C, and 42°C, and DAPI staining of their nucleoids at 42°C (40°C for I91L+W133V strain). (See Supplementary Figure S1 for images of other low fitness mutant strains). In parallel to the detrimental effect of temperature on fitness, we noted that the morphologies were also temperature-sensitive. I91L+W133V and V75H+I91L+I155A strains exhibited a 1.5-1.75 fold increase (comparatively to WT) in the average cell length at 37°C ( Figure 1E ), while W133V and V75H+I155A were not elongated at 37°C. The latter, however, showed an increase up to 2.0-2.3 fold over WT cell lengths at 42°C ( Figure 1F ). Strains I91L+W133V and V75H+I91L+I155A showed 1.8-2.0 fold increase in the average cell length at 40°C, with some cells reaching up to 20μm in length (about 10 fold increase) ( Figure S1 ).
Besides temperature of growth, since filamentation was also strongly dependent on availability of amino acids in the growth medium, it seemed likely that it was the result of a metabolic response and not due to effect on the mutant DHFR proteins per se.
Filamentation is due to drop in DHFR activity
DHFR is a central metabolic enzyme that is involved in conversion of dihydrofolate to tetrahydrofolate, and the latter is an important 1-carbon donor in the biosynthesis of purines, pyrimidines, and certain amino acids like glycine and methionine. Earlier we had reported that fitness effects of the mutant DHFR strains was primarily due to very low abundance of the mutant proteins in the cell ((Bershtein et al., 2015; Bershtein et al., 2013) and Figure S2 ), an effect that could be rescued by deletion of Lon protease or by over-expressing chaperones like GroEL-ES (Bershtein et al., 2013) . We, therefore, reasoned that filamentation could be a result of drop in DHFR activity in these cells. To confirm this, we supplemented the E. coli strains carrying chromosomal DHFR mutations with WT DHFR expressed from a plasmid and found that both filamentation ( Figure 2A ) and growth defects ( Figure 2B ) were fully rescued. On WT background, expression of extra DHFR resulted in some elongation, presumably due to toxicity of DHFR over-expression (Bhattacharyya et al., 2016) . We also found that plasmid expression of mutant proteins in WT cells did not result in any filamentation ( Figure 2C ) or growth defects ( Figure 2D ). This shows that filamentation is not due to toxicity of the mutant DHFR proteins.
Since filamentation is triggered by drop in DHFR activity, we hypothesized that treatment of WT cells with TMP, an antibiotic that targets bacterial DHFR, should also result in a similar phenotype. We treated WT E. coli cells with varying amounts of TMP at 37°C and 42°C. While we did observe filamentation and a drop in growth rates ( Figure S3 ), cell length showed a nonmonotonic dependence on TMP concentration at both temperatures ( Figure S4 at 37°C, Figure 2E at 42°C). Cell length increased at low concentrations of TMP to reach a maximum at one-half of MIC (0.5μg/ml, MIC of TMP is 1μg/ml (Rodrigues et al., 2016; Tamer et al., 2019; Toprak et al., 2012) ), and progressively decreased to 'no drug' levels at higher concentrations. This phenomenon is much more prominent at 42°C than 37°C, presumably because soluble DHFR amounts are lower at 42°C due to aggregation (Bershtein et al., 2012) . Going a step ahead, we treated mutant DHFR strains with varying concentrations of TMP and found that filamentation steadily disappeared at higher concentrations of the drug ( Figure 2F ). It, therefore, seems that mutant DHFR strains mimic WT cells treated with sub-MIC levels of TMP. In other words, filamentation happens within a certain narrow range of the intracellular DHFR activity. Sequestration/loss of the entire pool of DHFR (which happens at much higher concentrations of TMP) presumably lead to growth arrest, while filamentation requires that the cell continues to synthesize its cellular mass, albeit poorer than WT.
Filamentous strains have imbalance between dTTP and other deoxyribonucleotides
Kwon et al (Kwon et al., 2010) have shown that inhibition of intracellular DHFR with very high concentration of TMP (6μg/ml) incurs large metabolic changes in the cell, with drop in glycine, methionine, purines and thymine levels. Similar data have been reported for engineered E. coli cells containing inactive mutants of DHFR (Rodrigues and Shakhnovich, 2019) . However, as discussed in the previous section ( Figure 2E ), we found that cells treated with high concentrations of TMP were phenotypically (with regard to cell length) very different than those treated with sub lethal concentrations. Moreover, since presence of amino acids is crucial to obtaining the filamentous phenotype, detecting the metabolic changes under these conditions is central to understanding the processes that trigger cell filamentation. To that end, we carried out metabolomics analysis of mutant strains under conditions of filamentation (in amino acid supplemented M9 medium at 42°C for WT and W133V and at 40°C for I91L+W133V) as well as under non-filamentation conditions (in minimal medium at 42°C for WT and W133V and at 40°C for I91L+W133V). In addition, we did similar analysis for WT cells treated with low TMP concentration (0.5μg/ml at 42°C, a condition that mimics phenotype of mutant strains and causes filamentation in the presence of amino acids) under both set of media conditions (with and without amino acids). We observed that in the absence of amino acids, mutant strains as well as TMP-treated WT exhibited very low levels of both purines and pyrimidines ( Figure 3A shows levels relative to WT for I91L+W133V, while Figure S5A , B shows relative levels for W133V and WT+TMP, respectively; see Table S1 for data for all metabolites). Specifically, IMP levels were 5% of WT in W133V, 17% in I91L+W133V and 49% in TMP treated cells, while AMP levels were 47% of WT in W133V, 30% in I91L+W133V and 62% in TMP treated cells. In case of pyrimidines, dTMP levels were only 3% and 5% of WT levels in W133V and I91L+W133V, respectively, while dTTP levels in both were below the detection limit. Most amino acids showed large drop in abundance in mutant strains and following TMP treatment ( Figure 3C for I91L+W133V; see Figure S5A , B for others). Surprisingly, many were not directly related to the folate biosynthesis pathway. Methionine and glycine biosynthesis require tetrahydrofolate derivatives, hence, expectedly, methionine levels were only 1-3% in mutant strains and 11% in TMP treated cells. However, in contrast to Kwon et al (Kwon et al., 2010) , glycine levels were unaltered in mutant strains, and only dropped by 10% in TMP treated cells. Overall, we rationalize that large drop in methionine and purine (IMP) levels presumably stalls protein/RNA synthesis. Since increase in cell mass is essential for filamentation, cells under this condition are not filamented.
In the presence of 1% casamino acids, several but not all amino acids showed a marked increase in abundance ( Figure 3D for I91L+W133V; see Figure S5 for others; see Table S1 for data for all metabolites). Methionine levels rose to 40% of WT levels for I91L+W133V mutant, while they increased much above WT levels for W133V strain and TMP-treated cells.
Aspartate/asparagine, glutamine, histidine and tryptophan levels also showed a significant increase.
Particularly interesting was the fact that purine levels were substantially rescued upon addition of amino acids ( Figure 3B for I91L+W133V; see Figure S5A , B for others; see Figure S6 for metabolite concentrations as a function of time). IMP showed the maximal effect, increasing to 10-similar trends. Pyrimidine levels, in particular dTMP, also increased to 40-50% of WT levels. So, how does addition of amino acids lead to rescue of purine and pyrimidines despite low DHFR activity? We rationalize this observation in two possible ways. First, tetrahydrofolate, the product of DHFR activity, is used to synthesize 5,10-methylene-THF, which is eventually consumed in synthesis of methionine (through MetF/MetH), dTMP (through ThyA), and IMP (through FolD/PurH) ( Figure S7A ). In the presence of methionine in the medium, higher amounts of 5,10methylene-THF can be channeled towards synthesis of dTMP and IMP. Second, both de novo purine and pyrimidine biosynthesis pathways require aspartate and glutamine ( Figure S7B , C), which were otherwise low in minimal medium. Therefore, supplementation with amino acids removes this bottleneck, presumably leading to more efficient utilization of low THF amounts.
However, the question remains: Why are cells filamented despite rescue of purine and pyrimidine levels? Interestingly, we found that though dTMP levels much improved (to ~40-50% of WT levels) in the presence of amino acids, dTTP (thymidine derivative that is incorporated in the DNA) continued to be low, being only 3% of WT levels for I91L+W133V (at 40°C), and 18% for W133V (at 40°C) ( Figure 3B for I91L+W133V; see Figure S5A , B for others; Figure S6 for metabolites as a function of time). In contrast, dATP and dCTP levels were very high ( Figure 3B , Figure S5A , B). We hypothesize that misbalance in the concentrations of deoxy-nucleotides may lead to erroneous DNA replication, induction of SOS response and blocked cell division. Indeed, in our previous study, proteomics and transcriptomics analyses showed that several SOS response genes were upregulated in I91L+W133V and V75H+I91L+I155A strains at 37°C (Bershtein et al., 2015) .
Filamentation and SOS response: Deletion of recA rescues filamentation
To gain a deeper understanding of the SOS response on growth medium conditions and filamentation, we quantified the expression of several SOS genes recA, recN and sulA under different supplementation conditions for mutant DHFR strains as well as TMP-treated WT cells. At 37°C, WT and mutant W133V were not elongated, and not surprisingly, they did not elicit any SOS response ( Figure 4A -C). In comparison, I91L+W133V mutant (which is already elongated at 37°C) induced a strong SOS response with a 5-fold increase in recA expression, 7-fold increase in recN levels while sulA expression levels were 12-fold over WT ( Figure 4A -C). At 42°C, where both W133V and I91L+W133V are elongated, all three genes had elevated expression compared to WT, with expressions for I91L+W133V higher than those at 37°C ( Figure S8 ). There was no induction of SOS response when cells were grown in the absence of amino acids, and much reduced levels of induction in the presence of thymine (dTMP), consistent with lack of filamentation under these two conditions ( Figure 4A -C). Similar trends were also observed for WT treated with TMP.
RecA is the primary indicator of DNA damage, which cleaves the dimeric LexA repressor to turn on the genes that are under the SOS box (e.g., sulA, uvr proteins, etc.). SulA inhibits the cell division protein FtsZ, eventually causing filamentation. To understand the role of recA and sulA in our study, we treated ΔrecA and ΔsulA strains with near-MIC levels of the antibiotic TMP. As expected, ΔrecA strain did not show filamentation upon TMP treatment ( Figure 4D ), clearly highlighting its definitive role in filamentation. However, ΔsulA strain continued to filament ( Figure 4D ), indicating that sulA-independent pathways are also at play (Hill et al., 1997) . Overall, these results clearly establish the role of the SOS pathway towards filamentation in mutant DHFR strains, which in turn is due to imbalance between dTTP and other deoxynucleotides in the cell.
Misbalance of deoxynucleotides is due to inhibition of Thymidylate Kinase (Tmk)
We next asked the question: why are dTTP levels low despite relatively high dTMP levels ( Figure   5A )? The pyrimidine biosynthesis pathway ( Figure S7C ) involves conversion of dUMP to dTMP through Thymidylate synthase (ThyA). dTMP is then converted to dTDP using another essential enzyme Thymidylate Kinase (Tmk), which is further phosphorylated to form the triphosphate (dTTP) by Nucleotide Kinase (Ndk). To find out which step is getting inhibited, we looked at the levels of dTDP in mutant cells under conditions of filamentation. We found that dTDP levels were already low ( Figure 5A ), indicating that presumably the first step in the phosphorylation pathway involving Tmk is inhibited. Previous reports suggest that dUMP and dCTP can act as competitive inhibitors for Tmk (Nelson and Carter, 1969) , and interestingly, we found that both dUMP and dCTP levels were highly upregulated in mutant cells ( Figure S9 ), due to inefficient conversion of dUMP to dTMP in the presence of low DHFR activity ( Figure S7C ). We hypothesized that there might be two ways to overcome the competitive inhibition: a) to express more Tmk enzyme from a plasmid and b) to provide more of Tmk's natural substrate thymidylate monophosphate (dTMP) in the medium. To that end, we first measured cell length of mutant DHFR strains that were transformed with pBAD plasmid expressing Thymidylate Kinase (Tmk) from an arabinose inducible promoter. However, this experiment was inconclusive as expression of Tmk in WT strain resulted in filamentation ( Figure S10 ). Hence, we resorted to the second way to relieve inhibition:
we grew WT and mutant strains in minimal medium that was supplemented with both amino acids and dTMP and carried out measurement of cell length as well as metabolomics as a function of time. We found that I91L+W133V mutant had much higher levels of both dTDP and dTTP relative to WT under this condition ( Figure 5B ). Since the ratio of product to substrate concentration should ideally reflect on the efficiency of an enzyme, we reasoned that this ratio should be higher for Tmk upon dTMP supplementation. Indeed, the ratio of dTDP:dTMP returned to WT levels for mutant I91L+W133V upon addition of dTMP in the medium ( Figure 5C , upper panel), which was otherwise much below WT, indicating a relief of Tmk inhibition. In contrast, dTTP:dTDP ratios in both WT and mutant were similar even upon supplementation of dTMP ( Figure 5C , lower panel), indicating that Ndk was not responsible for lowered dTTP levels in mutants. More importantly, addition of dTMP concomitantly rescued filamentation ( Figure 5D ). Since dATP/dCTP levels remained high despite addition of dTMP ( Figure S11A ), we conclude that higher amounts of dTTP presumably reduce the imbalance in relative concentrations of deoxy-nucleotides, thus relieving DNA damage and filamentation (see above)).
Moreover, supplementation of dTMP and amino acids also allowed mutants W133V, I91L+W133V and V75H+I91L+I155A to form higher counts of colony forming units (cfu) than with only amino acids at their respective filamentation temperatures (42°C for W133V and 40°C for I91L+W133V and V75H+I91L+I155A) ( Figure 5E shows images for V75H+I91L+I155A). However, we note that cfu count for mutants in the presence of dTMP were still orders of magnitude lower than those of WT, indicating that thymine only rescues cell length, and not growth defects. This was also supported by the absence of growth rate rescue with dTMP ( Figure S11B ). However, when both purine source (GMP) and dTMP were supplemented along with amino acids, both cell length and growth rate were rescued ( Figure 5D , S11B).
Filamentation in mutant DHFR strains is not due to TLD and is reversible
A moderate level of thymine deficiency -thymine limitation -affects cell shape by increasing its diameter but not the length, making cells less rod-like, and certainly not filamentous (Pritchard and Zaritsky, 1970; Zaritsky and Pritchard, 1973) . A more severe level of thymine deprivation causes, under certain conditions, thymineless death (TLD), a phenomenon accompanied by cell filamentation (Ahmad et al., 1998; Bazill, 1967; Sangurdekar et al., 2011; Zaritsky et al., 2006) . Sangurdekar et al (Sangurdekar et al., 2010; Sangurdekar et al., 2011) also showed that thymine limitation is metabolically different from thymineless death, as DNA damage and SOS induction happens only in the latter, and cell death happening due to erroneous DNA replication. The phenotypic, metabolic as well as expression signatures of mutant DHFR strains seemed therefore, to resemble a case of thymine deprivation and TLD. To find out if mutant strains indeed represented a case of TLD, we assessed the viability of mutant strains at 30°C (permissive temperature) on solid media after several hours of growth at 42°C (restrictive temperature) in the presence of amino acids (filamentation condition). Sangurdekar et al (Sangurdekar et al., 2010) reported exponential loss in viability in TLD after one hour of growth under thymineless conditions. The idea was that if cells underwent TLD under conditions of filamentation, they would no longer be able to grow/form colonies at permissive temperature. We carried out this experiment in two different ways: First, we induced filamentous phenotype by incubating W133V mutant cells for 4 hours at 42°C, and then monitored cell recovery at room temperature (see Materials and
Methods). Figure 6A shows a representative example of morphology of W133V filament that begins to undergo slow division initiated at the poles at permissive temperature. Most progeny cells of normal size appeared after 5-6 hours of growth at low temperature. Second, we grew mutant strains at 42°C for 6 hours, and subsequently allowed them to grow at 30°C (permissive temperature) on solid media to check colony forming ability ( Figure 6B) . Surprisingly, both W133V and I91L+W133V mutants grew to similar extents as WT at the permissive temperature after 6 hours of growth at restrictive temperature, indicating no loss in viability ( Figure 6B ). Both these experiments clearly demonstrated that despite the extensive DNA damage and filamentation, mutant cells did not represent a case of TLD. Interestingly, even when WT cells were treated with varying concentrations of TMP at 42 o C in the presence of amino acids, there was no loss in viability at any concentration tested ( Figure 6C ). Rather, cfu counts did not change at concentrations higher than MIC, indicating that in minimal media supplemented with amino acids, TMP as well as mutants are bacteriostatic and not bactericidal.
Mutants do not cause TLD even upon purine supplementation
Kwon et al (Kwon et al., 2010) showed that when both amino acid and a purine source are supplemented, lethal doses of TMP treatment leads to TLD. To test the validity of this result at lower concentrations of TMP, we treated WT E. coli cells with a gradient of TMP concentrations for 6 hours at 42°C in the presence of both amino acids and a purine source (GMP) and assayed for viability at permissive temperature following that. As shown in Figure 7A , cells showed loss in viability only at TMP concentrations near to or higher than the MIC (≥1μg/ml). Since mutant cells mimic sublethal concentrations of TMP treatment (~0.5μg/ml), we hypothesized that even mutants should retain viability after exposure to amino acid and GMP at high temperature. Indeed, cells retained viability as good as without added purine source ( Figure 6B ), indicating again that filamentation is completely reversible. In terms of phenotype, mutant cells grown with amino acids and GMP were not only filamentous, but also exhibited condensed nucleoids, presumably indicating severity of DNA damage (Figure 7B, C) . As expected, metabolomics under this condition showed extreme imbalance in relative levels of deoxynucleotides: extremely high dATP and dCTP levels, while dTTP levels were too low to detect ( Figure 7D ). Not surprisingly, addition of a purine source largely increased the extent of DNA damage as shown by the SOS response genes ( Figure 7E ). Despite this, the fact that cells were still viable shows that to a large extent, DNA damage can be recovered. This is also exemplified from our previous study which showed significant upregulation of DNA damage repair genes in filamentous strains, besides SOS genes (Bershtein et al., 2015) . Nevertheless, this study highlights the considerable overlap that exists between characteristics of thymine limitation and thymineless death and emphasizes the fact that these two conditions are not an all or none phenomenon.
Discussion
Metabolic networks of cells are inherently intertwined, with substrates and products of one pathway being utilized by another pathway. As a result, perturbations produced in one pathway can easily percolate into others, usually magnifying effects. The folate pathway or the 1-carbon metabolism pathway is a classic example of this, as reduced folates act as 1-carbon donors during biosynthesis of purines, pyrimidines and amino acids. Kwon et al (Kwon et al., 2008) showed that for inhibition of DHFR activity using trimethoprim, accumulation of substrate dihydrofolate (DHF), in turn, results in inhibition of another downstream enzyme critical to folate metabolism:
folylpoly-gamma-glutamate synthetase (FP-gamma-GS), much like a domino effect (falling DHFR activity triggers a fall in the other enzyme's activity too). A similar domino effect was also observed for the drug Phloretin in Trypanosoma brucei, which functions primarily by inhibiting the glucose transporter of the deadly parasite. However, the drug also causes down-regulation of the transporter mRNA levels as well as drop in the glycolytic flux, thus rendering the parasite even more vulnerable to the drug (Haanstra et al., 2011) .
In this work, we show that in E. coli strains that harbor destabilizing mutations in folA gene, reduced DHFR activity is reflected, among other factors, in the pyrimidine biosynthesis pathway by inefficient production of dTMP from dUMP via thymidylate synthase (ThyA) that uses a derivative of THF as one carbon source. This causes accumulation of upstream metabolites dUMP and dCTP, which happen to be competitive inhibitors of the next enzyme in the pathway Thymidylate Kinase In our case, mutant DHFR strains accumulate very high levels of dUMP and dCTP, hence we presume that Tmk inhibition arises through competitive binding of dUMP at the dTMP binding site and of dCTP at the ATP binding site (Nelson and Carter, 1969) . Such instances where structural homologs of substrates act as competitive inhibitors are relatively common in nucleotide binding enzymes. It has been shown that binding of GTP at the ATP binding site can inhibit the activity of adenylate kinase (Rogne et al., 2018) , while nucleotide kinase (Ndk) can use a relatively diverse set of nucleotide triphosphates and diphosphates as phosphate donors and acceptors, respectively (Roisin and Kepes, 1978) . However, enzymes overcome this apparent lack of substrate selectivity by maintaining fine balance among metabolite concentrations inside the cell. For example, undetectably low levels of dUMP in WT cells prevent inhibition of Tmk under normal conditions. Intracellular dCTP levels are generally much smaller than ATP (35μM dCTP vs 9.6mM of ATP) (Bennett et al., 2008) . However, mutant DHFR cells accumulate dCTP more than 14 times over WT levels while ATP increases by 3 fold, thereby increasing the overall likelihood of inhibition. Therefore, under conditions of loss of metabolic homeostasis in the cell, several enzymes that utilize nucleotide (mono-, di-, tri-) phosphates as substrates become especially vulnerable to inhibition of function through promiscuous binding of ligands that are structural mimics. Hence, our case of Tmk inhibition might be more of a norm rather than an exception.
A remarkable aspect of the current study is the finding is that mutant DHFR cells do not lose viability despite indications of substantial DNA damage. This points to the large buffering capacity of the cell in terms of repair of damaged DNA. This is also supported by our earlier finding based on proteomics and transcriptomics data that besides SOS pathway proteins, DNA damage repair proteins were also significantly upregulated (Bershtein et al., 2015) . Sangurdekar et al (Sangurdekar et al., 2010; Sangurdekar et al., 2011) argue that DNA damage is the most salient feature that distinguishes between thymine limitation and thymineless death (TLD). Our results however indicate that it is possible to incur DNA damage and still retain reversibility. In fact, our data indicates that thymine limitation and TLD are the two ends of a spectrum, with considerable variability in between.
Several previous studies (Amyes and Smith, 1974; Kwon et al., 2010; Sangurdekar et al., 2011) have showed that high concentrations of antibiotic trimethoprim (5-6μg/ml) induce thymineless death in rich medium. Here, by systematically varying the concentration of TMP, we show that TMP is only bacteriostatic at or below the MIC, even in rich media supplemented with both amino acids and purines, and TLD happens only at lethal doses of the drug. Conversely, in minimal medium supplemented only with amino acids, near-MIC level of the drug causes filamentation like mutant DHFR strains. Overall, reversible filamentation and DNA damage under this condition might play an important role in the evolution of antibiotic resistance and persistence at sub-lethal TMP concentrations.
Unlike eukaryotic cells which have distinct stages of cell cycle and growth, prokaryotes like E. coli coordinate cytoplasmic growth, DNA replication and cell division simultaneously to achieve balanced growth. It has been argued that it is cellular metabolism that efficiently coordinates these processes (Sperber and Herman, 2017) . Several metabolic pathways, for example TCA cycle (Monahan et al., 2014) , nitrogen metabolism (Beaufay et al., 2015) , pyruvate metabolism (Monahan et al., 2014) , glucose metabolism (Hill et al., 2013; Weart et al., 2007) , etc., have been implicated to control cell shape and size. One or more proteins in these pathways have moonlighting functions, whereby they directly interact with the main modulators of cell division, MreB and FtsZ besides carrying out their own enzymatic function. In this work, mutant DHFRs modulate cell length through the SOS pathway, which ultimately blocks division through a SulA dependent or independent pathway. This is unlike most other pathways, where the mechanism is through direct interaction with MreB or FtsZ. Regardless of the mechanism, this work uncovers how another central metabolic pathway, the folate or 1-carbon metabolism pathway can reversibly modulate size and shape of E. coli in a mechanism that is fundamentally different from TLD. increases the cfu by several orders at the same temperature, while supplementation with both dTMP and purine (GMP) allows it to grow as good as WT. In comparison, WT was grown at 42°C under different supplementation conditions. In all cases, cultures were 7-fold serially diluted for the next spot. The three rows (two rows for WT) in each condition represent biological replicates. See related figures S7, S9, S10 and S11. 
Figure legends
STAR Methods
Strains and media. The design principles of mutant DHFR strains were reported previously (Bershtein et al, 2012) . M9 minimal medium without amino acids was only supplemented with 0.2% glucose and 1mM MgSO 4 while M9 media with amino acids was supplemented with 0.2% glucose, 1mM MgSO 4 , 0.1% casamino acids, and 0.5 μg/ml thiamine. Casamino acids is a commercially available mixture of all amino acids except tryptophan, and cysteine is present in a very small amount. Wherever mentioned, 1mM GMP was used as a source of purine, while 1mM dTMP (thymidine monophosphate) was used as a source of thymine. Folate mix consists of M9 minimal medium supplemented with 1 mM adenine, 1 mM thymine, 1 μg/mL D-panthothenate, 0.5 mM glycine, and 0.5 mM methionine.
Growth conditions. All strains were grown overnight from a single colony at 30°C, and subsequently the culture was diluted to a final OD 600 of 0.01 in the specified medium and allowed to grow for 16-18 hours in Bioscreen C (Growth Curves, USA) at 30°C, 37°C or 42°C.
Growth curves were fit to a 4-parameter Gompertz equation as described in (Bhattacharyya et al., 2017) to derive growth parameters. Error bars were calculated as SEM of three biological replicates.
Light microscopy. Cells were grown overnight at 30°C from a single colony in the specified medium, diluted 1/100, and grown at various temperatures for 4 hours. For DIC images in Figures 1C, 1D , 7B, 7C and Figure S1 , cells were pelleted, washed with PBS, and concentrated. DAPI staining (Molecular probes) was performed for 10 min at RT according to manufacturer instructions. 1 μl of a concentrated culture was then mounted on a slide and slightly pressed by a cover slip. DIC and DAPI images were obtained at room temperature by Nikon Ti Eclipse Microscope equipped with iXon EMCCD camera (Andor Technologies). For live phase contrast images and time-lapse experiments ( Figure 6A ), cells were mounted on supplemented M9 + 1.5% low melting agarose (Calbiochem) pads. Pads were then flipped on #1.5 glass dish (Willco Wells), and the images were acquired at room temperature with Zeiss Cell Observer microscope.
For DIC images in Figure S9 , cells were placed on agar pads and images were acquired with Zeiss Cell Discoverer microscope.
Analysis of cell lengths. MicrobeTracker Suite [http://microbetracker.org/] (Sliusarenko et al., 2011 ) was used to obtain distributions of cell length for phase contrast images and Zeiss
Intellesis Module was used to analyze DIC images. On average, 500 cells were analyzed for each presented distribution.
Statistical analysis.
In our experiments, cell lengths of E. coli were not normally distributed.
Hence non-parametric Mann-Whitney test was used to determine if the distribution of cell lengths of two samples were significantly different.
Metabolomics. Cells were grown overnight at 30°C from a single colony in the specified medium, diluted 1/100, and re-grown. WT, WT+0.5μg/ml TMP and W133V mutant were grown at 42°C, while mutant I91L+W133V was grown at 40°C. For time course experiment, aliquots were removed after 2, 4, 6 and 8 hours, and metabolites were extracted as described in (Bhattacharyya et al., 2016) . Metabolite levels were averaged over 2-3 biological replicates. A linear regression of replicate SD vs the replicate average showed that absolute errors (constant) was nearly zero, while relative errors were ~15% of the mean. Hence error bars in Figures 3,   4(A, B) , 7D, Figure S5 , S8, S10A represent 15% of the mean value.
Expression of SOS response genes by qPCR. Cells were grown overnight at 30°C from a single colony in the specified medium, diluted 1/100, and grown at 37°C or 42°C for 4 hours.
Based on OD 600 of the cultures, a volume equivalent to 5×10 8 cells were spun down (assuming 1 OD 600 =8×10 8 cells) and Protect Bacteria RNA Mini Kit (Qiagen) was used to extract total RNA as described in (Bhattacharyya et al., 2018) . Following reverse transcription (Bhattacharyya et al., 2018) , expression of recA, recN and sulA genes were quantified using QuantiTect SYBR Green PCR kit (Qiagen) using the following primers: As it was difficult to find a reference gene that would be expressed to similar levels in WT vs mutant DHFR strains, we used total RNA to normalize the expression levels.
Expression levels reported are average of 2-3 biological replicates. A similar error analysis as discussed in Metabolomics section showed that relative errors were ~12% of the mean. Hence error bars in Figures 4(A, B , C) and 7(E, F, G) represent 12% of the mean value.
Supplemental Information
The manuscript contains 11 Supplementary figures (Figure S1-S11) and 1 Supplementary table. W133V and V75H+I155A were grown for 4 hours at 42°C while I91L+W133V and V75H+I91L+I155A strains were grown for 4 hours at 40°C in amino acid supplemented M9 medium before being harvested. The data is also reported in (Bershtein et al., 2015) . Figure S3 . The effect of WT DHFR inhibition by trimethoprim (TMP) on growth. WT DHFR cells were grown at 42°C in amino acid M9 medium, and their growth was monitored by OD at 600nm. The data were fit to a 4-parameter Gompertz equation as described in (Bhattacharyya et al., 2017) to derive growth parameters. Filamentation is much pronounced when cells are grown at 42°C (see Figure 2E ). for WT E. coli without and with 0.5μg/ml TMP as well as mutants W133V and I91L+W133V when grown in amino acid supplemented M9 medium at 42°C (40°C for I91L+W133V). The plot also includes metabolite abundances for WT and I91L+W133V grown in the presence of 1mM dTMP in amino acid supplemented M9 medium. All values are normalized with respect to abundance of that metabolite obtained for WT after 2 hours of growth. Comparison of growth rates of WT and mutant DHFR strains at 42°C (40°C for I91L+W133V and V75H+I91L+I155A) in minimal medium that is supplemented with amino acids and/or
